心膜炎の世界市場レポート 2024年

心膜炎市場規模は近年力強く成長しています。2023年の21億7,000万米ドルから2024年には23億5,000万米ドルへと、CAGR8.4％で拡大します。過去の期間に見られた成長は、心血管疾患の有病率の増加、疾患リスクの高い高齢化、疾患病態生理学の理解向上、ヘルスケアサービスの世界化、進行中の医薬品開発と技術革新など、いくつかの要因に起因しています。

心膜炎市場規模は、今後数年間で力強い成長が見込まれます。2028年には年間平均成長率（CAGR）8.1％で32億米ドルに成長します。予測期間中に予想される成長は、精密医療への注目の高まり、希少疾病用医薬品に対する規制当局の支援、患者擁護・支援団体の影響力、炎症経路に関する研究の拡大、心血管疾患予防を目指した世界の取り組みなどに起因すると考えられます。予測期間に予想される主な動向には、診断技術の進歩、診断における人工知能の統合、再発心膜炎に対する管理戦略の改善、フォローアップケアにおける遠隔医療の導入、患者教育とサポートの重視、画像技術の強化などがあります。

予測される心血管疾患の増加は、心膜炎市場の成長を促進します。心血管疾患には、心臓や血管に影響を及ぼすさまざまな疾患が含まれ、多くの場合、動脈への脂肪沈着物の蓄積や血液凝固リスクの上昇を伴います。心膜炎の流行は、放置すれば重篤な心血管合併症を引き起こし、死に至ることさえある状態であり、心血管疾患の増加率と密接に結びついています。米国では、2022年10月に疾病対策予防センター（CDC）が発表した記事によると、心臓発作は40秒に1回の割合で発生しており、年間約80万5,000人の米国人が心臓発作を経験していると報告されています。喫煙、高血圧、高コレステロールなどの要因に起因する心血管疾患の罹患率の上昇が、心膜炎機器市場の成長の原動力となっています。

ヘルスケア支出の増加は、心膜炎市場を大きく押し上げると予想されます。ヘルスケア支出は、さまざまなヘルスケアサービスや活動に割り当てられる財源を表し、調査や診断から治療や患者教育まで、心膜炎の包括的な管理を支えています。2022年3月のメディケア＆メディケイドサービスセンターによる2021-2030年国民医療費（NHE）報告書によると、国民医療費は2021年から2030年の間に年平均5.1％増加し、約6兆8,000億米ドルに達すると予測されています。このような医療支出の増加は、調査、診断、治療の進歩を確実にし、心膜炎に取り組むための環境を作り出します。特に、メディケアとメディケイド支出の増加が予測され、心膜炎市場全体の成長にさらに貢献しています。

2023年の心膜炎市場で最大の地域は北米でした。アジア太平洋は、心膜炎市場レポートにおいて予測期間中に最も急成長する地域となる見込みです。心膜炎市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 心膜炎市場の特徴

第3章 心膜炎市場の動向と戦略

第4章 心膜炎市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の心膜炎市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 心膜炎市場セグメンテーション

• 世界の心膜炎市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 急性心膜炎
• 慢性心膜炎
• 再発性心膜炎
• 世界の心膜炎市場、診断・治療別セグメンテーション、過去と予測、2018-2023年、2023-2028年、2033年
• 心電図（ECG）
• 心エコー図
• コンピュータ断層撮影法（Ct）
• X線
• 薬剤
• 外科的治療
• 世界の心膜炎市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院と診療所
• 医療機関
• 外来手術センター
• 研究機関

第7章 心膜炎市場の地域および国分析

• 世界の心膜炎市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の心膜炎市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋心膜炎市場

第9章 中国心膜炎市場

第10章 インドの心膜炎市場

第11章 日本の心膜炎市場

第12章 オーストラリアの心膜炎市場

第13章 インドネシアの心膜炎市場

第14章 韓国の心膜炎市場

第15章 西欧の心膜炎市場

第16章 英国の心膜炎市場

第17章 ドイツの心膜炎市場

第18章 フランスの心膜炎市場

第19章 イタリア心膜炎市場

第20章 スペインの心膜炎市場

第21章 東欧の心膜炎市場

第22章 ロシアの心膜炎市場

第23章 北米心膜炎市場

第24章 米国の心膜炎市場

第25章 カナダの心膜炎市場

第26章 南米心膜炎市場

第27章 ブラジル心膜炎市場

第28章 中東の心膜炎市場

第29章 アフリカ心膜炎市場

第30章 心膜炎市場の競合情勢と企業プロファイル

• 心膜炎市場の競合情勢
• 心膜炎市場の企業プロファイル
  • Pfizer Inc.
  • AstraZeneca plc
  • Allergan plc
  • Merck &Co. Inc.
  • Bayer AG

第31章 世界の心膜炎市場の競合ベンチマーキング

第32章 世界の心膜炎市場競争ダッシュボード

第33章 心膜炎市場における主要な合併と買収

第34章 心膜炎市場の将来展望と可能性分析

第35章 付録

“Pericarditis Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pericarditis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pericarditis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pericarditis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Acute Pericarditis; Chronic Pericarditis; Recurrent Pericarditis
• 2) By Diagnosis And Treatment: Electrocardiogram (ECG); Echocardiogram; Computerized Tomography (Ct); X-Ray; Medication; Surgical Treatment
• 3) By Application: Hospitals And Clinics; Medical Institutes; Ambulatory Surgical Centers; Research Organizations
• Companies Mentioned: Pfizer Inc.; AstraZeneca plc; Allergan plc; Merck & Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Pericarditis is a condition characterized by inflammation and irritation of the thin, sac-such as tissue known as the pericardium, which surrounds the heart. The primary symptom is chest pain, resulting from the rubbing of inflamed sac layers against the heart.

There are three major types of pericarditis, acute pericarditis, chronic pericarditis, and recurrent pericarditis. Acute pericarditis involves a sudden and painful inflammation in the pericardium surrounding the heart. Diagnosis and treatment of pericarditis involve various methods, including electrocardiogram (ECG), echocardiogram, computerized tomography (CT), X-ray, medication, and, in some cases, surgical intervention. The treatment of pericarditis is applied in different healthcare settings, such as hospitals, clinics, medical institutes, ambulatory surgical centers, and research organizations.

The pericarditis market research report is one of a series of new reports from The Business Research Company that provides pericarditis market statistics, including pericarditis industry global market size, regional shares, competitors with a pericarditis market share, detailed pericarditis market segments, market trends and opportunities, and any further data you may need to thrive in the pericarditis industry. This pericarditis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pericarditis market size has grown strongly in recent years. It will grow from $2.17 billion in 2023 to $2.35 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to several factors, including the increased prevalence of cardiovascular diseases, an aging population with higher disease risks, improved understanding of disease pathophysiology, globalization of healthcare services, and ongoing drug development and innovation.

The pericarditis market size is expected to see strong growth in the next few years. It will grow to $3.2 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The anticipated growth in the forecast period can be attributed to increased attention on precision medicine, regulatory support for orphan drugs, the influence of patient advocacy and support groups, expanding research on inflammatory pathways, and global efforts aimed at cardiovascular disease prevention. Major trends expected in the forecast period include advances in diagnostic technologies, the integration of artificial intelligence in diagnostics, improved management strategies for recurrent pericarditis, the incorporation of telemedicine in follow-up care, a focus on patient education and support, and enhancements in imaging technologies.

The anticipated rise in cardiovascular diseases is set to drive the growth of the pericarditis market. Cardiovascular diseases encompass various conditions affecting the heart or blood vessels, often associated with the accumulation of fatty deposits in arteries and an elevated risk of blood clotting. The prevalence of pericarditis, a condition that can lead to severe cardiovascular complications or even death if left untreated, is closely tied to the increasing rates of cardiovascular diseases. In the United States, an article from the Centers for Disease Control and Prevention (CDC) in October 2022 reported that a heart attack occurs every 40 seconds, with approximately 805,000 Americans experiencing a heart attack annually. The rising incidence of cardiovascular diseases, attributed to factors such as smoking, high blood pressure, and high cholesterol, is a driving force behind the pericarditis devices market's growth.

The growth in healthcare spending is expected to provide a significant boost to the pericarditis market. Healthcare spending, representing the financial resources allocated for various healthcare services and activities, supports the comprehensive management of pericarditis-from research and diagnosis to treatment and patient education. According to the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services in March 2022, national health spending is projected to increase by an average of 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. This increase in healthcare spending creates a conducive environment for addressing pericarditis, ensuring advancements in research, diagnosis, and treatment. Notably, the projected rise in Medicare and Medicaid spending further contributes to the overall growth of the pericarditis market.

Leading companies in the pericarditis market are focusing on innovation, introducing products such as valves for pericardial tissues to cater to broader customer bases and drive revenue growth. Valves for pericardial tissues are designed for use in cardiac surgery, particularly in procedures involving heart valve replacement or repair. Edwards Lifesciences, a US-based technology company, launched the SAPIEN 3 Ultra RESILIA valve in September 2022. This innovative valve integrates advanced anti-calcification technology, addressing a crucial factor contributing to the need for reintervention following heart valve replacement. The introduction of such products reflects a commitment to innovation, meeting the evolving needs of patients and enhancing their overall health and longevity.

Innovative products, such as therapies for recurrent pericarditis, are being developed by major companies in the pericarditis market to cater to a wider audience and boost revenue. Therapies for recurrent pericarditis involve medical interventions and treatment strategies aimed at managing and preventing the recurrence of pericardium inflammation. Kiniksa Pharmaceuticals Ltd., a Bermuda-based biotechnology company, received FDA approval for ARCALYST in March 2021. ARCALYST is a subcutaneously-injected recombinant fusion protein designed to obstruct interleukin-1 alpha (IL-1α) and interleukin-1 beta (IL-1B) signaling. Specifically developed for treating recurrent pericarditis, ARCALYST demonstrated significant improvements in clinical trials, addressing an unmet medical need in the management of recurrent pericarditis.

In March 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, acquired Arena Pharmaceuticals for USD 6.7 million. This acquisition positions Pfizer to expand its portfolio with diverse and developmental-stage therapeutic candidates in the inflammation and immunology therapeutic areas. Arena Pharmaceuticals, a US-based biopharmaceutical company, is actively developing potential therapies for immuno-inflammatory diseases, including innovative medications undergoing extensive testing for various disorders.

Major companies operating in the pericarditis market report are Pfizer Inc., AstraZeneca plc, Allergan plc, Merck & Co. Inc., Bayer AG, Reckitt Benckiser Group plc, PerkinElmer Inc., Novartis International AG, Sanofi S.A., Johnson & Johnson Services Inc., Takeda Pharmaceutical Co. Ltd., Zydus Cadila Healthcare Ltd., Sun Pharmaceutical Ltd., Regeneron Pharmaceuticals Inc., Kiniksa Pharmaceuticals Ltd., R-Pharm International LLC, Unimed Laboratories, Teva Pharmaceutical Industries Ltd., Swedish Orphan Biovitrum AB, Cigna Group, Hikma pharmaceutical plc, Wockhardt Ltd., XYMAS Pharmaceutical, Sakura Finetek USA Inc., Hitachi High-Technologies Corporation, Leica Biosystems Nussloch GmbH, Euromex Microscopen BV, Celestron LLC, Labomed Inc., Olympus Corporation, Bruker Corporation .

North America was the largest region in the pericarditis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the pericarditis market report during the forecast period. The regions covered in the pericarditis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pericarditis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pericarditis market consists of sales of bacterial pericarditis, viral pericarditis, constrictive pericarditis, and subacute pericarditis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The pericarditis market is segmented into bacterial pericarditis, viral pericarditis, constrictive pericarditis and other pericarditis.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Pericarditis Market Characteristics

3. Pericarditis Market Trends And Strategies

4. Pericarditis Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Pericarditis Market Size and Growth

• 5.1. Global Pericarditis Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pericarditis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pericarditis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pericarditis Market Segmentation

• 6.1. Global Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Acute Pericarditis
• Chronic Pericarditis
• Recurrent Pericarditis
• 6.2. Global Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Electrocardiogram (ECG)
• Echocardiogram
• Computerized Tomography (Ct)
• X-Ray
• Medication
• Surgical Treatment
• 6.3. Global Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Medical Institutes
• Ambulatory Surgical Centers
• Research Organizations

7. Pericarditis Market Regional And Country Analysis

• 7.1. Global Pericarditis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pericarditis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pericarditis Market

• 8.1. Asia-Pacific Pericarditis Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pericarditis Market

• 9.1. China Pericarditis Market Overview
• 9.2. China Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pericarditis Market

• 10.1. India Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pericarditis Market

• 11.1. Japan Pericarditis Market Overview
• 11.2. Japan Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pericarditis Market

• 12.1. Australia Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pericarditis Market

• 13.1. Indonesia Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pericarditis Market

• 14.1. South Korea Pericarditis Market Overview
• 14.2. South Korea Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pericarditis Market

• 15.1. Western Europe Pericarditis Market Overview
• 15.2. Western Europe Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pericarditis Market

• 16.1. UK Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pericarditis Market

• 17.1. Germany Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pericarditis Market

• 18.1. France Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pericarditis Market

• 19.1. Italy Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pericarditis Market

• 20.1. Spain Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pericarditis Market

• 21.1. Eastern Europe Pericarditis Market Overview
• 21.2. Eastern Europe Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pericarditis Market

• 22.1. Russia Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pericarditis Market

• 23.1. North America Pericarditis Market Overview
• 23.2. North America Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pericarditis Market

• 24.1. USA Pericarditis Market Overview
• 24.2. USA Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pericarditis Market

• 25.1. Canada Pericarditis Market Overview
• 25.2. Canada Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pericarditis Market

• 26.1. South America Pericarditis Market Overview
• 26.2. South America Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pericarditis Market

• 27.1. Brazil Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pericarditis Market

• 28.1. Middle East Pericarditis Market Overview
• 28.2. Middle East Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pericarditis Market

• 29.1. Africa Pericarditis Market Overview
• 29.2. Africa Pericarditis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pericarditis Market, Segmentation By Diagnosis and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pericarditis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pericarditis Market Competitive Landscape And Company Profiles

• 30.1. Pericarditis Market Competitive Landscape
• 30.2. Pericarditis Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. AstraZeneca plc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Allergan plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck & Co. Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Pericarditis Market Competitive Benchmarking

32. Global Pericarditis Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pericarditis Market

34. Pericarditis Market Future Outlook and Potential Analysis

• 34.1 Pericarditis Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Pericarditis Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Pericarditis Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer